Hormonal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Annales d'Endocrinologie

Volumn 68, Issue 4, 2007, Pages 274-280

  Bachelot, A ^a   Chakhtoura, Z ^a   Rouxel, A ^a   Dulon, J ^a   Touraine, P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

21 OH deficiency; Adrenal rest tumours; Body mass index; Bone mineral density; Congenital adrenal hyperplasia; Fertility

Indexed keywords

FLUDROCORTISONE; FOLLITROPIN; GLUCOCORTICOID; STEROID 21 MONOOXYGENASE;

ARTICLE; BONE DENSITY; BONE MINERAL; CONGENITAL ADRENAL HYPERPLASIA; CORTICOSTEROID THERAPY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DUAL ENERGY X RAY ABSORPTIOMETRY; EARLY DIAGNOSIS; ENDOCRINE FUNCTION TEST; FEMALE FERTILITY; FEMALE INFERTILITY; FOLLITROPIN RELEASE; HORMONAL THERAPY; HUMAN; LONG TERM CARE; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; MALE INFERTILITY; SCORING SYSTEM; SEXUAL BEHAVIOR; STEROID 21 MONOOXYGENASE DEFICIENCY; ADULT; BODY MASS; CHILD; FEMALE; INFERTILITY; MALE; REVIEW;

ADRENAL HYPERPLASIA, CONGENITAL; ADULT; BODY MASS INDEX; BONE DENSITY; CHILD; FEMALE; GLUCOCORTICOIDS; HUMANS; INFERTILITY; MALE; STEROID 21-HYDROXYLASE;

EID: 34548462593     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2007.06.019     Document Type: Article

References (62)

1. White P.C., and Speiser P.W. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr. Rev. 21 (2000) 245-291
2. Dupont B., Oberfield S.E., Smithwick E.M., Lee T.D., and Levine L.S. Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency). Lancet 2 (1977) 1309-1312
3. Levine L.S., Zachmann M., New M.I., Prader A., Pollack M.S., O'Neill G.J., et al. Genetic mapping of the 21-hydroxylase-deficiency gene within the HLA linkage group. N. Engl. J. Med. 299 (1978) 911-915
4. Morel Y., Tardy V., Costa J.M., Forest M.G., and David M. 21-hydroxylase deficiency: new strategies emerging from molecular studies. Ann. Endocrinol. (Paris) 64 (2003) 456-470
5. Merke D.P., and Bornstein S.R. Congenital adrenal hyperplasia. Lancet 365 (2005) 2125-2136
6. Therrell B.L. Newborn screening for congenital adrenal hyperplasia. Endocrinol. Metab. Clin. North Am. 30 (2001) 15-30
7. Charmandari E., Johnston A., Brook C.G., and Hindmarsh P.C. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Endocrinol. 169 (2001) 65-70
8. Charmandari E., Matthews D.R., Johnston A., Brook C.G., and Hindmarsh P.C. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?. J. Clin. Endocrinol. Metab. 86 (2001) 4679-4685
9. Ross R.J., and Rostami-Hodjegan A. Timing and type of glucocorticoid replacement in adult congenital adrenal hyperplasia. Horm. Res. 64 Suppl 2 (2005) 67-70
10. Cutler Jr. G.B., and Laue L. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N. Engl. J. Med. 323 (1990) 1806-1813
11. Guo C.Y., Weetman A.P., and Eastell R. Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia. Clin. Endocrinol. (Oxf.) 45 (1996) 535-541
12. Gussinye M., Carrascosa A., Potau N., Enrubia M., Vicens-Calvet E., Ibanez L., et al. Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia. Pediatrics 100 (1997) 671-674
13. Mora S., Saggion F., Russo G., Weber G., Bellini A., Prinster C., et al. Bone density in young patients with congenital adrenal hyperplasia. Bone 18 (1996) 337-340
14. Stikkelbroeck N.M., Oyen W.J., van der Wilt G.J., Hermus A.R., and Otten B.J. Normal bone mineral density and lean body mass but increased fat mass in young adult patients with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 88 (2003) 1036-1042
15. Girgis R., and Winter J.S. The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 82 (1997) 3926-3929
16. Christiansen P., Molgaard C., and Muller J. Normal bone mineral content in young adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm. Res. 61 (2004) 133-136
17. Jaaskelainen J., and Voutilainen R. Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency. Clin. Endocrinol. (Oxf.) 45 (1996) 707-713
18. Hagenfeldt K., Ritzen E.M., Ringertz H., Helleday J., and Carlstrom K. Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy. Eur. J. Endocrinol. 143 (2000) 667-671
19. Cameron F.J., Kaymakci B., Byrt E.A., Ebeling P.R., Warne G.L., and Wark J.D. Bone mineral density and body composition in congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 80 (1995) 2238-2243
20. Paganini C., Radetti G., Livieri C., Braga V., Migliavacca D., and Adami S. Height, bone mineral density and bone markers in congenital adrenal hyperplasia. Horm. Res. 54 (2000) 164-168
21. de Almeida Freire P.O., de Lemos-Marini S.H., Maciel-Guerra A.T., Morcillo A.M., Matias Baptista M.T., de Mello M.P., et al. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross-sectional study of factors involved in bone mineral density. J. Bone Miner. Metab. 21 (2003) 396-401
22. King J.A., Wisniewski A.B., Bankowski B.J., Carson K.A., Zacur H.A., and Migeon C.J. Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 9 (2006) 865-869
23. Sciannamblo M., Russo G., Cuccato D., Chiumello G., and Mora S. Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 91 (2006) 4453-4458
24. Bachelot A., P-Bureau G., Thibaud E., Laborde K., Pinto G., Samara D., et al. Touraine: Long-term outcome of pateints with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm. Res. 67 (2006) 268-276 (Epub ahead of print)
25. Gallagher M.P., Levine L.S., and Oberfield S.E. A review of the effects of therapy on growth and bone mineralization in children with congenital adrenal hyperplasia. Growth Horm. IGF Res. 15 Suppl (2005) S26-S30
26. Cornean R.E., Hindmarsh P.C., and Brook C.G.D. Obesity in 21-hydroxylase deficient patients. Arch. Dis. Child. 78 (1998) 261-263
27. Volkl T.M., Simm D., Beier C., and Dorr H.G. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 117 (2006) e98-e105
28. Falhammar H., Filipsson H., Holmdahl G., Janson P.O., Nordenskjold A., Hagenfeldt K., et al. Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-Hydroxylase Deficiency. J. Clin. Endocrinol. Metab. 92 (2007) 110-116
29. Sartorato P., Zulian E., Benedini S., Mariniello B., Schiavi F., Bilora F., et al. Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs, and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 92 (2007) 1015-1018
30. Huppert J., Chiodi M., and Hillard P.J. Clinical and metabolic findings in adolescent females with hyperandrogenism. J. Pediatr. Adolesc. Gynecol. 17 (2004) 103-108
31. Golden S.H., Ding J., Szklo M., Schmidt M.I., Duncan B.B., and Dobs A. Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study. Am. J. Epidemiol. 160 (2004) 540-548
32. Speiser P.W., Serrat J., New M.I., and Gertner J.M. Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 75 (1992) 1421-1424
33. Charmandari E., Weise M., Bornstein S.R., Eisenhofer G.R., Keil M.F., Chrousos G.P., et al. Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. J. Clin. Endocrinol. Metab. 87 (2002) 2114-2120
34. Roche E.F., Charmandari E., Dattani M.T., and Hindmarsh P.C. Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report. Clin. Endocrinol. (Oxf.) 58 (2003) 589-596
35. Volkl T.M., Simm D., Dotsch J., Rascher W., and Dorr H.G. Altered 24-hour blood pressure profiles in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 91 (2006) 4888-4895
36. Mulaikal R.M., Migeon C.J., and Rock J.A. Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N. Engl. J. Med. 316 (1987) 178-182
37. Premawardhana L.D., Hughes I.A., Read G.F., and Scanlon M.F. Longer-tem outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience. Clin. Endocrinol. (Oxf.) 46 (1997) 327-332
38. Krone N., Wachter I., Stefanidou M., Roscher A.A., and Schwarz H.P. Mothers with congenital adrenal hyperplasia and their children: outcome of pregnancy, birth and childhood. Clin. Endocrinol. (Oxf.) 55 (2001) 523-529
39. Lo J.C., and Grumbach M.M. Pregnancy outcomes in women with congenital virilizing adrenal hyperplasia. Endocrinol. Metab. Clin. North Am. 30 (2001) 207-229
40. Azziz R., Mulaikal R.M., Migeon C.J., Jones Jr. H.W., and Rock J.A. Congenital adrenal hyperplasia: long-term results following vaginal reconstruction. Fertil. Steril. 46 (1986) 1011-1014
41. Helleday J., Siwers B., Ritzen E.M., and Carlstrom K. Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 76 (1993) 933-936
42. Holmes-Walker D.J., Conway G.S., Honour J.W., Rumsby G., and Jacobs H.S. Menstrual disturbance and hypersecretion of progesterone in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin. Endocrinol. (Oxf.) 43 (1995) 291-296
43. Barnes R.B., Rosenfield R.L., Ehrmann D.A., Cara J.F., Cuttler L., Levitsky L.L., et al. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J. Clin. Endocrinol. Metab. 79 (1994) 1328-1333
44. Stikkelbroeck N.M., Beerendonk C., Willemsen W., Schreuders-Bais C.A., Feitz W., Rieu P., et al. The long term outcome of feminizing genital surgery for congenital adrenal hyperplasia: anatomical, functionaland cosmetic outcomes, psychosexual development, and satisfaction in adult female patients. J. Pediatr. Adolesc. Gynecol. 16 (2003) 289-296
45. Alizai N.K., Thomas D.F., Lilford R.J., Batchelor A.G., and Johnson N. Feminizing genitoplasty for congenital adrenal hyperplasia: what happens at puberty?. J. Urol. 161 (1999) 1588-1591
46. Creighton S.M., Minto C.L., and Steele S.J. Objective cosmetic and anatomical outcomes at adolescence of feminising surgery for ambiguous genitalia done in childhood. Lancet 358 (2001) 124-125
47. Gastaud F., Bouvattier C., Duranteau L., Brauner R., Thibaud E., Kutten F., et al. Impaired sexual and reproductive outcomes in women with classical forms of congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 92 (2007) 1391-1396
48. Ogilvie C.M., Crouch N.S., Rumsby G., Creighton S.M., Liao L.M., and Conway G.S. Congenital adrenal hyperplasia in adults: a review of medical, surgical and psychological issues. Clin. Endocrinol. (Oxf.) 64 (2006) 2-11
49. Claahsen-van der Grinten H.L., Hulsbergen-van de Kaa C.A., and Otten B.J. Ovarian adrenal rest tissue in congenital adrenal hyperplasia: a patient report. J. Pediatr. Endocrinol. Metab. 19 (2006) 177-182
50. Russo G., Paesano P., Taccagni G., Del Maschio A., and Chiumello G. Ovarian adrenal-like tissue in congenital adrenal hyperplasia. N. Engl. J. Med. 339 (1998) 853-854
51. Al Ahmadie H.A., Stanek J., Liu J., Mangu P.N., Niemann T., and Young R.H. Ovarian "Tumour" of the adrenogenital syndrome-the first reported case. Am. J. Surg. Pathol. 25 (2001) 1443-1450
52. Stikkelbroeck N.M., Hermus A., Schouten D., Suliman H., Jager G., Braat D., et al. Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging. Eur. Radiol. 14 (2004) 1802-1806
53. Hughes I.A. Congenital adrenal hyperplasia: 21-hydroxylase deficiency in the newborn and during infancy. Semin. Reprod. Med. 20 (2002) 229-242
54. Forest M.G., Tardy V., Nicolino M., David M., and Morel Y. 21-Hydroxylase deficiency: an exemplary model of the contribution of molecular biology in the understanding and management of the disease. Ann. Endocrinol. (Paris) 66 (2005) 225-232
55. New M.I., Carlson A., Obeid J., Marshall I., Cabrera M.S., Goseco A., et al. Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J. Clin. Endocrinol. Metab. 86 (2001) 5651-5657
56. Cabrera M.S., Vogiatzi M.G., and New M.I. Long-term outcome in adult males with classic congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 86 (2001) 3070-3078
57. Stikkelbroeck N., Otten B.J., Pasic A., Jager G.J., Sweep C., Noordam K., et al. High prevalence of testicular adrenal rest tumours, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 86 (2001) 5721-5728
58. Blumberg-Tick J., Boudou P., Nahoul K., and Schaison G. Testicular tumours in congenital adrenal hyperplasia: steroid measurements from adrenal and spermatic veins. J. Clin. Endocrinol. Metab. 73 (1991) 1129-1133
59. Walker B.R., Skoog S.J., Winslow B.H., Canning D.A., and Tank E.S. Testis sparing surgery for steroid unresponsive testicular tumours of the adrenogenital syndrome. J. Urol. 157 (1997) 1460-1463
60. Claahsen-van der Grinten H.L., Otten B.J., Takahashi S., Meuleman E.J., Hulsbergen-van de Kaa C., Sweep F.C., et al. Testicular adrenal rest tumours in adult males with congenital adrenal hyperplasia: evaluation of pituitary-gonadal function before and after successful testis-sparing surgery in 8 patients. J. Clin. Endocrinol. Metab. 92 (2007) 612-615
61. Bachelot A., Chanson P., Rocher L., Salenave S., Laborde K., Kuttenn F., et al. Effects of Mitotane on testicular adrenal rest tumours size, sperm count and adrenal steroidogenesis in patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. ESPE/LWPES 7th Joint Meeting in Paedriatric Endocrinology. Horm. Res. 64 S1 (2005) 42
62. Stikkelbroeck N.M., Suliman H.M., Otten B.J., Hermus A.R., Blickman J.G., and Jager G.J. Testicular adrenal rest tumours in postpubertal males with congenital adrenal hyperplasia: sonographic and MR features. Eur. Radiol. 13 (2003) 1597-1603